Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Kawada T; Department of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan.
Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications
-
Source:
European journal of neurology [Eur J Neurol] 2024 Jul; Vol. 31 (7), pp. e16274. Date of Electronic Publication: 2024 Mar 07.Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Pate A; Centre for Health Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; Sperrin M
Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Models, Statistical* ; Computer Simulation*
-
Source:
Statistics in medicine [Stat Med] 2024 Jun 30; Vol. 43 (14), pp. 2830-2852. Date of Electronic Publication: 2024 May 08.Publisher: Wiley Country of Publication: England NLM ID: 8215016 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Tan GSQ; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Hospitalization*/Hospitalization*/Hospitalization*/statistics & numerical data ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy
-
Source:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jun; Vol. 115 (6), pp. 1304-1315. Date of Electronic Publication: 2024 Feb 09.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Scairati R; Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Università Federico II di Napoli, Naples, Italy.; Auriemma RS
Subjects: Prolactin*/Prolactin*/Prolactin*/metabolism ; Prolactin*/Prolactin*/Prolactin*/physiology ; Diabetes, Gestational*/Diabetes, Gestational*/Diabetes, Gestational*/metabolism
-
Source:
European journal of clinical investigation [Eur J Clin Invest] 2024 Jun; Vol. 54 (6), pp. e14190. Date of Electronic Publication: 2024 Mar 12.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Xie T; Center for Evidence-Based Medicine, Nantong University Medical School, Nantong, China.; Information Center, The People's Hospital of Rugao, Nantong, China.
Subjects: Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Decision Making, Shared*
-
Source:
Health expectations : an international journal of public participation in health care and health policy [Health Expect] 2024 Jun; Vol. 27 (3), pp. e14059.Publisher: Wiley Country of Publication: England NLM ID: 9815926 Publication Model: Print Cited Medium: Internet ISSN:
Record details
-
Authors :
Natale P; Sydney School of Public Health, The University of Sydney, Sydney, Australia.; Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications
-
Source:
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 May 21; Vol. 5. Cochrane AN: CD015588. Date of Electronic Publication: 2024 May 21.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet
Record details
